CD86 and neoplasm: It is possible that the CD86/CD28 costimulatory signal primarily affected the survival and activation of memory CD4 T-cells, which were associated with OS and RFS (Figure 6) and could kill tumor cells (Golubovskaya and Wu, 2016).